Pure Global AI
NCT06321458Recruiting

Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity

Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity: the LightWAY Randomised Trial: Lighthouse Consortium on Obesity Management (LightCOM) Trial no 3
Carsten DirksenClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Obesity
Drug/Device/Intervention
Intensive weight loss intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Carsten Dirksen
Funder
Copenhagen University Hospital, Hvidovre
Location
Frederiksberg,Frederiksberg,Hvidovre,Hvidovre,Søborg,Oxford, Denmark,United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Apr 29, 2024
End date
Dec 01, 2048
Enrollment
600 participants
Primary outcome

MetS-Z,Weight

Summary

In this trial, the aim is to assess the clinical benefits and harms, as well as
 cost-effectiveness of an intensive weight loss (IWL) intervention that includes total dietary
 replacements, behavioural support and weight-loss medication compared with existing weight
 management programmes within primary care for people with severe and complex obesity.

ICD-10 classifications
ObesityOther obesityObesity, unspecifiedObesity due to excess caloriesObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06321458
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06321458 through Pure Global AI's free database. This phase not specified trial is sponsored by Carsten Dirksen and is currently Recruiting. The study focuses on Obesity. Target enrollment is 600 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.